Amgen has finally closed its $27.8 billion takeover of Horizon Pharma, which was held up for several months by opposition from financial regulators. The company confirmed that it had completed the ...
The pharma sector's run of merger and acquisitions continues, with two new deals worth $1 billion-plus from Teva and Horizon announced yesterday. While the announcements weren't among the biggest ...
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...
We are excited to announce the initiation of our HORIZON Study for MZE829, a Phase 2 clinical trial with a novel, potential new medicine that could disrupt current treatment for AKD,” said Harold ...
Maze Therapeutics (MAZE) announced the first patient has been dosed in the company’s Phase 2 clinical trial, the HORIZON Study, of MZE829 in ...
UroGen Pharma Ltd. (NASDAQ:URGN) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. UroGen Pharma Ltd., a biotechnology company, engages ...
The president offered a proclamation Saturday to begin duties on Canada, Mexico, and China. Musk says Tesla's robotaxis will hit Austin this summer. But after years of unfulfilled promises, investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback